A Screening of Antineoplastic Drugs for Acute Myeloid Leukemia Reveals Contrasting Immunogenic Effects of Etoposide and Fludarabine

Background: Recent evidence demonstrated that the treatment of acute myeloid leukemia (AML) cells with daunorubicin (DNR) but not cytarabine (Ara-C) results in immunogenic cell death (ICD). In the clinical setting, chemotherapy including anthracyclines and Ara-C remains a gold standard for AML treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ocadlikova, Darina, Iannarone, Clara, Redavid, Anna Rita, Cavo, Michele, Curti, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556041/
https://www.ncbi.nlm.nih.gov/pubmed/32948017
http://dx.doi.org/10.3390/ijms21186802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556041/
https://www.ncbi.nlm.nih.gov/pubmed/32948017
http://dx.doi.org/10.3390/ijms21186802

Ejemplares similares